Aileron Therapeutics Intangible Assets

Aileron Therapeutics (ALRN) currently reports a intangible assets of $14M as of March 2026. That compares with $42M in the prior-year period — down 68.0% year over year. Use the charts on this page to explore Aileron Therapeutics's intangible assets history and peer comparisons.

Aileron Therapeutics's intangible assets decreased from $42M to $14M — a 68.0% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Aileron Therapeutics reported $14M in intangible assets as of March 2026. That compares with $42M in the prior-year period — down 68.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $14M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Aileron Therapeutics, and consider following ALRN for alerts when major investors trade the stock.

Aileron Therapeutics is classified in the Healthcare sector. On intangible assets, it currently shows $14M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ALRN with unrelated industries.